Polycystic Ovary Syndrome
Conditions
Keywords
PCOS, SCUBE, Cardiovascular disease
Brief summary
The aim of this study is to investigate serum SCUBE-1 and SCUBE-3 levels in PCOS and non-PCOS cases compared with non-PCOS healthy controls with similar age and body mass index
Detailed description
The aim of this study was to investigate serum SCUBE1 and SCUBE3 levels in PCOS and non-PCOS cases compared with non-PCOS healthy controls with similar age and body mass index. This will be a prospective clinical laboratory study,It will include women with PCOS diagnosis (according to the 2003 Rotherdam criteria). 40 cases of reproductive age will be included in the study group, which will be included in the survey after being approved for participation in the survey from field trials. Forty patients who will not have any complaints between the ages of 18-35 who will apply to the gynecology policlinic as a control group but who had no PCOS o rany other systemic problems and will be similar in terms of age group and body mass index will be included in the study after being approved for participation in the study. From the study and control group, 5 mL of blood will be taken from the untreated biochemical tube for serum SCUBE1 SCUBE2 SCUBE3. The blood samples will be centrifuged at 1000 g for 10 minutes and the serum fraction will be obtained and the serum will be stored at -80 ° C to be stored until the day of the tube operation. Serum SCUBE1, SCUBE2 SCUBE3 levels will be measured using ELISA kits. ,
Interventions
DIAGNOSTIC_TESTstudy
Scube-1 scube-2 scube-3
Sponsors
Karadeniz Technical University
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
* Clinical diagnosis of PCOS * 18-35 years old
Exclusion criteria
* Endocrinopathies (including diabetes mellitus, hyperprolactinemia, Cushing's disease and congenital adrenal hyperplasia), systemic disease (eg asthma), collagen disorder, hypercholesterolemia, sickle cell anemia or neoplasm, * Coronary artery disease , angina or myocardial infarction, or any known vascular, infectious, or inflammatory disease, including hypertension, coronary arterioscitis, and electrocardiographic changes; * Use of any medication (e.g., insulin sensitizing drugs, oral contraceptives, antiandrogens, statins, aspirin, corticosteroids and gonadotropin releasing hormone agonists and antagonists) within the previous 3 months; * Abnormal serum albumin concentration (normal concentration, 30-55 g / l), * Abnormal troponin I concentration, * Present smoker, * Abnormal renal, hepatic and thyroid function test results; * Refusing to participate in the work.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum SCUBE 1 | 01.01.2017-31.12.2017 | Serum scube1 in microgram |
| Serum SCUBE 2 | 01.01.2017-31.12.2017 | Serum scube2 in microgram |
| Serum SCUBE 3 | 01.01.2017-31.12.2017 | Serum scube3 in microgram |
Countries
Turkey (Türkiye)
Outcome results
None listed